Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170063 · ClinicalTrials.gov registry record
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
A clinical trial of Parkinson Disease, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- Completed
- Registry status
- 54
- Enrollment target
- 5
- Study locations
NCT03170063 is a study of Parkinson Disease that has completed, run by Michael J. Fox Foundation for Parkinson's Research. The registered enrollment target is 54 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT03170063, a study of Parkinson Disease, has completed, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 5
- Study locations
Study Summary
The overall objective of this study is to compare the performance of available oligomeric and phosphorylated a-synuclein assay in cerebrospinal fluid and blood.
Conditions Studied
Interventions
- PROCEDURE Procedure/Surgery: Biofluid samplings
Study Locations (5)
Illinois
- Rush University Medical Center - Chicago
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Oregon
- Oregon Health and Sciences University - Portland
Pennsylvania
- University of Pennsylvania - Philadelphia
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-08-08 |
| Est. Completion | 2018-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03170063
The ClinicalTrials.gov registry entry for NCT03170063 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Michael J. Fox Foundation for Parkinson's Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Procedure/Surgery: Biofluid samplings is the first listed.
NCT03170063 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Illinois, Massachusetts, Oregon.
Frequently Asked Questions
What is clinical trial NCT03170063 about?
NCT03170063 is a clinical study titled "FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)". The overall objective of this study is to compare the performance of available oligomeric and phosphorylated a-synuclein assay in cerebrospinal fluid and blood.
What is the current status of trial NCT03170063?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-08-08. Estimated completion is 2018-03-12.
What conditions does trial NCT03170063 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT03170063?
The interventions under investigation include: Procedure/Surgery: Biofluid samplings (PROCEDURE).
Who is sponsoring clinical trial NCT03170063?
This trial is sponsored by Michael J. Fox Foundation for Parkinson's Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03170063 being conducted?
This trial has 5 study locations across Illinois, Massachusetts, Oregon, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.